BIOLASE, P+G Partner to Launch Light-Based Oral Care Devices

BIOLASE Technology, Inc. (NASDAQ: BLTI), the world's leading dental laser company, announced today that it has signed a license agreement with The Procter & Gamble Company (P&G) to enable BIOLASE to launch light-based oral care devices to dental professionals.

Negotiations concluded late last week with the signing of the agreement at P&G headquarters in Cincinnati. BIOLASE currently plans to market the new products to professionals through its primary distribution partner Henry Schein (NASDAQ: HSIC) and its other distribution partners around the world.

"This agreement on implementing a product launch is an important milestone in our partnership with Procter & Gamble, a proven, global leader in the development, sales and marketing of professional and consumer products," said BIOLASE Chief Executive Officer David M. Mulder. "We believe this product will further extend our brand nationally and globally and will bring us closer to consumers through the professional market. We have a long-term strategy of making the benefits of all our products, particularly the Waterlase®, well known to consumers."

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Biolase Technology, Inc.. (2019, March 01). BIOLASE, P+G Partner to Launch Light-Based Oral Care Devices. AZoOptics. Retrieved on November 21, 2024 from https://www.azooptics.com/News.aspx?newsID=9485.

  • MLA

    Biolase Technology, Inc.. "BIOLASE, P+G Partner to Launch Light-Based Oral Care Devices". AZoOptics. 21 November 2024. <https://www.azooptics.com/News.aspx?newsID=9485>.

  • Chicago

    Biolase Technology, Inc.. "BIOLASE, P+G Partner to Launch Light-Based Oral Care Devices". AZoOptics. https://www.azooptics.com/News.aspx?newsID=9485. (accessed November 21, 2024).

  • Harvard

    Biolase Technology, Inc.. 2019. BIOLASE, P+G Partner to Launch Light-Based Oral Care Devices. AZoOptics, viewed 21 November 2024, https://www.azooptics.com/News.aspx?newsID=9485.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.